1,2-distearoylphosphatidylethanolamine and Lymphoma, B-Cell

1,2-distearoylphosphatidylethanolamine has been researched along with Lymphoma, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, FH; Hong, RL; Tao, MH; Tseng, YL	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Lymphoma, B-Cell

Article	Year
Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model. International journal of cancer, 1999, Mar-01, Volume: 80, Issue:5 Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Doxorubicin; Drug Carriers; Endocytosis; Female; Liposomes; Lymphoma, B-Cell; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Phosphatidylethanolamines; Polyethylene Glycols	1999

Article

Year

Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model.

International journal of cancer, 1999, Mar-01, Volume: 80, Issue:5

Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Doxorubicin; Drug Carriers; Endocytosis; Female; Liposomes; Lymphoma, B-Cell; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Phosphatidylethanolamines; Polyethylene Glycols

1999